Clinical Guidance for PrEP

CDC | April 30, 2026

U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir

Gilead | April 29, 2026

State AIDS Drug Assistance Programs Linked to Higher HIV Viral Suppression Rates

IDA | April 28, 2026

Two-Drug, Single-Tablet Idvynso Receives FDA Approval for HIV-1

IDA | April 24, 2026

New study reveals few pharmacists prescribe “game-changer” HIV prevention drug

UC Berkeley | April 22, 2026

Monthly Islatravir Shows Comparable Safety for HIV PrEP, Lowers Lymphocyte Counts

IDA | April 6, 2026

Viral Suppression and an Undetectable Viral Load

HIV.gov | April 2, 2026

Existing medication could improve the health of people living with HIV

News Medical | March 23, 2026

What are the most important things to know about nevirapine?

HIV.gov | March 13, 2026

Bicillin® L-A Shortage

CDC | March 10, 2026

Long-acting medications transform HIV prevention, treatment

Healio | March 6, 2026

A Thorough Analysis of Changing Antibiotic Resistance in Dental Practice: A Narrative Review

Cureus | February 19, 2026

Drug Interactions with Antiretroviral Medications

National HIV Curriculum | February 12, 2026

What drugs are contained in the HIV treatment Symtuza?

Drugs.com | February 9, 2026

First of its kind daily HIV treatment shows promising results

Queen Mary University of London | February 9, 2026

Drug Database: Emtricitabine / Tenofovir Disoproxil Fumarate

HIV.gov | February 5, 2026

‘Transformative’ HIV PrEP shot slowly overcomes cost hurdles

The Hill | January 28, 2026

HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir

Nature | January 27, 2026

PrEP

CMS.gov | January 20, 2026

Single-Tablet BIC/LEN Shows Good Results in Phase 3 for HIV Treatment

IDSE | January 16, 2026

New Once Weekly Investigational Oral Regimen Shows Strong 48 Week Results, Highlighting the Need for Easier HIV Treatment Options

UNC School of Medicine | January 16, 2026

Prior authorization and HIV medications: Considerations for state policymakers

hivma | January 16, 2026

Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents

St Jude Children’s Research Hospital | January 15, 2026

PrEP Offers Everyone Protection From HIV

Cleveland Clinic | January 14, 2026

HIV infection Prevention in 2026: How PrEP Can Almost Eliminate Your HIV Risk

Doral Health & Wellness | January 13, 2026

Charity report urges government to commission PrEP through pharmacies

ThePhamaJournal | January 2, 2026